StockVS

Huntsman Corporation (HUN) Stock Analysis

Basic Materials

Huntsman Corporation

$14.74

+$0.23 (+1.59%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Huntsman Corporation manufactures and sells a diverse array of organic chemical products globally, operating specifically within the basic materials sector under the chemicals industry classification. This positioning places the firm in a domain focused on the production of essential raw materials and intermediate compounds required for various downstream manufacturing processes. The company's scale is defined by a market capitalization of $2.20B, annual revenue of $5.68B, and an organizational structure employing 6,000 individuals. These valuation and revenue figures indicate that Huntsman operates as a mid-to-large-cap entity with significant global reach, though the specific market cap suggests a valuation that may be compressed relative to its revenue base. The presence of 6,000 employees across its operations underscores the substantial physical footprint required to sustain production in the polyurethanes, performance products, and advanced materials segments.

Financial Health

The company reported revenue of $5.68B for the trailing twelve months, yet recorded a net income loss of $275,000,000 while generating an EBITDA of $264.00M. The substantial disparity between the positive EBITDA of $264.00M and the negative net income of $275,000,000 reveals a significant cost structure burden, likely driven by high interest expenses or other non-operating charges that erode bottom-line profitability despite operational cash generation. Despite the net income deficit, the company maintains positive free cash flow of $218.25M, which indicates a degree of financial flexibility allowing for capital return or strategic investments independent of accounting profits. The gross margin stands at 13.2%, reflecting moderate pricing power relative to the cost of goods sold in the chemical sector. The operating margin is negative at -3.4%, signaling that operating expenses exceed operating revenue, while the profit margin of -5.0% confirms that overall profitability is currently compromised. In terms of liquidity and leverage, the company holds $429.00M in cash against total debt of $2.40B, resulting in a debt-to-equity ratio of 81.20, which characterizes a highly leveraged balance sheet. The current ratio of 1.30 suggests that the company possesses sufficient current assets to cover short-term liabilities, though the buffer is relatively narrow. Return on Equity is -7.1% and return on assets is -0.1%, metrics that collectively reveal that management is currently failing to generate returns on the capital invested, indicating a period of value destruction rather than value creation.

Valuation Assessment

The valuation metrics present a complex picture, with a trailing P/E ratio listed as N/A due to the lack of earnings, while the forward P/E is quoted at 83.65. The divergence between a non-existent trailing multiple and a high forward P/E implies that the market expects a significant turnaround in earnings trajectory to justify the current share price. The price-to-book ratio is 0.79, indicating that the market values the company at a discount to its book value, suggesting the market does not currently assign a premium to the firm's tangible assets. Alternative valuation measures such as the price-to-sales ratio of 0.39 and an EV/EBITDA of 16.60 provide context; the low price-to-sales multiple suggests revenue is undervalued relative to the stock price, while the EV/EBITDA indicates the enterprise value is roughly 16.6 times its earnings before interest, taxes, depreciation, and amortization. Price metrics show a 52-week high of $16.76 and a 52-week low of $7.30, and based on the available data points, the current price sits at a level that reflects a long consolidation period below the recent highs. The beta value of 0.66 indicates that the stock's price volatility is significantly lower than that of the broader market, suggesting it may act as a defensive holding during periods of equity market turbulence.

Growth & Income

Revenue growth year-over-year is -6.7%, while earnings growth is N/A due to the reported net loss. The negative revenue growth indicates a contraction in top-line sales, and since earnings are already negative, a comparison of growth rates is not mathematically possible, though the loss implies that earnings are deteriorating faster than revenue has been declining or shrinking. As a dividend payer, the company offers a dividend yield of 2.8%, supported by a payout ratio of 180.0%. This payout ratio indicates that the company is distributing more in dividends than it is generating in net income, which raises questions regarding the sustainability of the dividend given the negative earnings of $275,000,000. The reliance on cash flow rather than net income to fund dividends suggests the company is drawing down on liquidity or utilizing free cash flow to maintain the payout. Overall, the growth and income profile presents a mixed picture characterized by declining revenue, negative earnings, a highly leveraged balance sheet, and a dividend yield that is currently unsustainable relative to reported net income.

Peer Comparison

Huntsman Corporation (HUN) operates in the Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Huntsman Corporation HUN $2.58B N/A
Dow Inc. DOW $25.43B N/A
Methanex Corporation MX.TO $6.43B N/A
Celanese Corporation CE $5.74B N/A

The Chemicals industry average P/E ratio is 29.3x. Huntsman Corporation trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Huntsman Corporation

Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products. The Performance Products segment manufactures amines, such as polyetheramines, ethyleneamines, DGA Agent, JEFFCAT catalysts, and E-GRADE specialty amines and carbonates. The Advanced Materials segment offers epoxy, phenoxy, acrylic, polyurethane, and acrylonitrile-butadiene-based polymer formulations; and thermoset resins, curing and toughening agents, and carbon nanomaterials. The company provides pre-and post-sales technical service support to customers. Its products are used in a range of applications, including adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, packaging, coatings and construction, power generation, and refining, as well as serves the elastomers, insulation, footwear, furniture, industrial, oil and gas, liquid natural gas transport, printed circuit boards, consumer, appliances, electrical power transmission and distribution, recreational sports equipment, food and beverage packaging, and medical appliances markets. It sells its products through a network of distributors and agents. The company was founded in 1970 and is headquartered in The Woodlands, Texas.

Visit website →

Key Statistics

Market Cap
$2.58B
P/E Ratio
N/A
52-Week High
$15.90
52-Week Low
$7.30
Avg Volume
6.16M
Beta
0.64
Dividend Yield
3.48%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Industry
Chemicals
Exchange
NYSE
Country
United States
Employees
6,000